Durect Corp.

Durect Corp.

Specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development. Learn more

Launch date
Employees
Market cap
€42.9m
Enterprise valuation
€43m (Public information from Sep 2024)
Cupertino California (HQ)
Authorizing premium user...